Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Peritoneal Primary Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT03180177
What this trial is testing

Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Shu-Zhong Cui 263
Testing effectiveness (Phase 2)UnknownNCT03462212
What this trial is testing

Carboplatin-Paclitaxel-Bevacizumab vs Carbo-Pacli-Beva-Rucaparib vs Carbo-Pacli-Ruca, Selected According to HRD Status, in Patients With Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer, Preceded by a Phase I Dose Escalation Study on Ruca-Beva Combination

Who this might be right for
Advanced (Stage IIIB-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 290
Early research (Phase 1)Study completedNCT00825201
What this trial is testing

Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity

Who this might be right for
Ovarian CancerPeritoneal Cavity CancerUnspecified Adult Solid Tumor, Protocol Specific
City of Hope Medical Center 27
Testing effectiveness (Phase 2)Study completedNCT00157560
What this trial is testing

Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed Mullerian Carcinoma

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Massachusetts General Hospital 83
Early research (Phase 1)Study completedNCT00539877
What this trial is testing

Phase I Study of Interperitoneal Chenotherapy in Patients With Gastric Adenocarainoma With Peritoneal Seeding

Who this might be right for
Stomach Neoplasms
Samsung Medical Center 17
Not applicableStudy completedNCT06184867
What this trial is testing

Choices About Genetic Testing And Learning Your Risk With Smart Technology

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer+5 more
Rutgers, The State University of New Jersey 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06602063
What this trial is testing

Surgery for Relapsed Ovarian Cancer in Precision

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Shanghai Gynecologic Oncology Group 33
Early research (Phase 1)Study completedNCT02996825
What this trial is testing

Mirvetuximab Soravtansine and Gemcitabine Hydrochloride in Treating Patients With FRalpha-Positive Recurrent Ovarian, Primary Peritoneal, Fallopian Tube, Endometrial, or Triple Negative Breast Cancer

Who this might be right for
Recurrent Breast CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Ovarian Carcinoma+3 more
City of Hope Medical Center 44
Testing effectiveness (Phase 2)Study completedNCT02657889
What this trial is testing

Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer

Who this might be right for
NeoplasmsTriple Negative Breast CancerOvarian Cancer+6 more
Tesaro, Inc. 122
Early research (Phase 1)Study completedNCT05483933
What this trial is testing

Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers

Who this might be right for
Platinum-resistant Ovarian CancerFallopian Tube CancerEpithelial Ovarian Cancer+4 more
Shattuck Labs, Inc. 86
Early research (Phase 1)UnknownNCT02433626
What this trial is testing

Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies

Who this might be right for
Ovarian CancerFallopian Tube CancerEndometrial Cancer+7 more
Critical Outcome Technologies Inc. 51
Testing effectiveness (Phase 2)Looking for participantsNCT03983226
What this trial is testing

Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)

Who this might be right for
Ovarian Cancer RecurrentFallopian Tube CancerPrimary Peritoneal Carcinoma
Shanghai Gynecologic Oncology Group 167
Large-scale testing (Phase 3)UnknownNCT03221608
What this trial is testing

Clinical Analysis of HIPEC for T4 Colorectal Cancer After Surgery

Who this might be right for
Colorectal Neoplasms
Sixth Affiliated Hospital, Sun Yat-sen University 300
Testing effectiveness (Phase 2)Study completedNCT07648745
What this trial is testing

Does Cediranib Prevent Bowel Perforation in Platinum-resistant Ovarian Cancer

Who this might be right for
Bowel ObstructionOvarian CancerFallopian Tube Cancer+1 more
Prof Gordon Jayson 30
Early research (Phase 1)Study completedNCT00066729
What this trial is testing

Vaccine Therapy in Treating Patients With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Ludwig Institute for Cancer Research 9
Not applicableActive Not RecruitingNCT06839157
What this trial is testing

Artificial Intelligence - Assisted Model for Optimal Timing of Surgery in Advanced Ovarian Cancer

Who this might be right for
Ovarian, Fallopian, and Primary Peritoneal CancerArtificial Intelligence (AI)
Shanghai Gynecologic Oncology Group 1,025
Testing effectiveness (Phase 2)WithdrawnNCT02836028
What this trial is testing

A Study Evaluating Talazoparib in Relapsed Ovarian, Fallopian Tube, and Peritoneal Cancer

Who this might be right for
Ovarian Cancer
Pfizer
Not applicableStudy completedNCT05539053
What this trial is testing

Efficacy of NAC for the Prevention and Relief of PIPN in Women With Ovarian, Tubal, and Peritoneal Cancer

Who this might be right for
Chemotherapy-induced Peripheral Neuropathy
Department of Medical Services Ministry of Public Health of Thailand 60
Testing effectiveness (Phase 2)Study completedNCT03657043
What this trial is testing

Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208)

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Seagen Inc. 98
Testing effectiveness (Phase 2)Study completedNCT03206047
What this trial is testing

Atezolizumab, Guadecitabine, and CDX-1401 Vaccine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Platinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Ovarian CarcinomaPlatinum-Resistant Primary Peritoneal Carcinoma+3 more
National Cancer Institute (NCI) 12
Next Page